Delivery Order SPE2DB22D3501-SPE2DB25FVS95
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,478.04 fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product, with a completion date of July 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,655.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4566964538 - RAMELTEON 8 MG TABLET UD 50S, with an ultimate completion date of January 17, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.38, is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.56 firm fixed-price delivery order covers the supply of Ramelteon 8 mg tablets for the DLA Troop Support Medical program. The contract has a period of performance through November 27, 2024 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RAMELTEON 8 MG TABLET UD 50S. The award has a ceiling value of $2,835.48 and an ultimate completion date of April 16, 2024. The contract type is Firm Fixed Price. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,669.96 firm-fixed-price delivery order is for the supply of 100 count bottles of the medication Ramelteon 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency awarded a delivery order valued at $407.47 to Amerisourcebergen Drug Corporation under an existing prime vendor contract vehicle. The firm fixed price order is for 4561888114 Ramelteon 8 mg tablets to be delivered by August 22, 2023 from the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor without the use of major subcontractors....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,256.86 firm-fixed-price delivery order is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,572.06 firm fixed-price delivery order is for the supply of 4,568,188,741 units of the prescription medication Ambien CR 12.5 mg tablets. The contract has an ultimate completion date of May 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...